Chimeric Therapeutics Limited (ASX:CHM)
Australia · Delayed Price · Currency is AUD 0.0480
-0.0050 (-9.43%)
Jul 15, 2026, 3:36 PM AEST
Chimeric Therapeutics Market Cap
Chimeric Therapeutics has a market cap or net worth of 2.82 million as of July 14, 2026. Its market cap has decreased by -65.03% in one year.
Market Cap
2.82M
Enterprise Value
315.00K
Revenue
9.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since January 18, 2021, Chimeric Therapeutics's market cap has decreased from 97.50M to 2.82M, a decrease of -97.11%. That is a compound annual growth rate of -47.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 2.82M | -65.70% |
| Dec 31, 2025 | 8.22M | -25.46% |
| Dec 31, 2024 | 11.02M | -56.60% |
| Dec 29, 2023 | 25.40M | -27.35% |
| Dec 30, 2022 | 34.97M | -59.93% |
| Dec 31, 2021 | 87.26M | -10.51% |
| Jan 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cambium Bio | 11.07M |
| Vectus Biosystems | 9.84M |
| Invex Therapeutics | 7.89M |
| Tissue Repair | 6.65M |
| Bio-Gene Technology | 6.56M |
| Zelira Therapeutics | 5.95M |
| Acrux | 5.90M |
| Biotron | 5.40M |